Argenx receives positive CHMP opinion for CIDP treatment - PharmaTimes VYVGART could be the first CIDP drug with a novel mechanism in 30 years

#Argenx #CHMP #CIDPtreatment #VYVGART #efgartigimodalfa #chronicinflammatorydemyelinatingpolyneuropathy #CIDPdrug #ADHEREtrial #CIDPclinicalstudy #IgGFcantibodyfragment #immunoglobulintherapy #CIPDpatients #EPODIN #CIPDmanagement #CHMPrecommendation #CHMPopinion
pharmatimes.com/news/argenx-...